Researchers Unveil Key Mechanism in Pancreatic Cancer Spread
Scientists from the UK and the United States have made significant strides in understanding how pancreatic cancer spreads, potentially paving the way for groundbreaking treatments for this deadly disease.
The collaborative research revealed that pancreatic cancer deactivates critical molecules in a key gene, accelerating the disease’s progression. This discovery is considered a potential game-changer in the fight against pancreatic cancer, which has the lowest survival rates among common cancers.
Pancreatic cancer is the 12th most common cancer worldwide, with over half a million new cases annually. The prognosis remains poor, with most patients succumbing within three months of diagnosis. Notable victims include Alan Rickman, John Hurt, Steve Jobs, and Patrick Swayze.
Expert insights
Dr. Maria Hatziapostolou from Nottingham Trent University’s John van Geest Cancer Research Centre highlighted the significance of the findings: “This work has provided new understanding and knowledge of how pancreatic cancer behaves. It will hopefully help pave the way for potential new treatments in the future.”
Key Findings: DNA Methylation
Published in the journal Gastro Hep Advances, the study analyzed healthy and cancerous pancreatic tissue samples. Researchers found that pancreatic cancer triggers DNA methylation, a process that deactivates molecules in the HNF4A gene, essential for organ function. This deactivation leads to rapid tumor growth.
“Loss of HNF4A drives pancreatic cancer development and aggressiveness, and we now know correlates with poor patient survival,” Dr. Hatziapostolou explained.
The project brought together scientists from the University of Nottingham, Stanford University, the University of California, and Cedars-Sinai Medical Centre in Los Angeles, marking a significant step forward in the global fight against pancreatic cancer.
